Phase
Condition
Cerebral Ischemia
Stroke
Treatment
Experimental Group (Mulligan Mobilization + Conventional Therapy)
(Conventional Therapy Only)
Clinical Study ID
Ages 30-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Participants must meet all of the following conditions to be eligible for the study:
Diagnosed with stroke by a neurologist.
Aged 30 to 65 years.
First-ever stroke (single episode).
Stroke duration between 6 to 24 months.
Score of ≤3 on the Modified Rankin Scale (mRS).
Score of ≥24 on the Mini-Mental State Examination (MMSE).
Exclusion
Exclusion Criteria:
Participants will be excluded if they meet any of the following conditions:
History of musculoskeletal disorders affecting the spine (e.g., cancer,scoliosis, spondylolisthesis, rheumatoid arthritis, ankylosing spondylitis).
Previous lumbar spine surgery.
Presence of neurological conditions other than stroke (e.g., Parkinson'sdisease, multiple sclerosis).
Severe visual impairment affecting balance or walking.
Study Design
Study Description
Connect with a study center
Ankara Yıldırım Beyazıt University
Ankara, 06010
TurkeyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.